BioPorto A/S (CPH: BIOPOR)
Denmark
· Delayed Price · Currency is DKK
1.592
+0.010 (0.63%)
Dec 19, 2024, 4:59 PM CET
BioPorto Employees
BioPorto had 29 employees as of December 31, 2023. The number of employees decreased by 3 or -9.38% compared to the previous year.
Employees
29
Change (1Y)
-3
Growth (1Y)
-9.38%
Revenue / Employee
969.61K DKK
Profits / Employee
-1.70M DKK
Market Cap
637.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk A/S | 64,319 |
Coloplast A/S | 16,639 |
Genmab A/S | 2,204 |
Demant A/S | 21,623 |
Zealand Pharma A/S | 253 |
H. Lundbeck A/S | 5,681 |
H. Lundbeck A/S | 5,681 |
ALK-Abelló A/S | 2,824 |
BioPorto News
- 5 weeks ago - BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 - GlobeNewsWire
- 5 weeks ago - BioPorto A/S to Host Third Quarter 2024 Earnings Webcast - GlobeNewsWire
- 6 weeks ago - BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences - GlobeNewsWire
- 7 weeks ago - First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital - GlobeNewsWire
- 7 weeks ago - BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests - GlobeNewsWire
- 2 months ago - BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference - GlobeNewsWire
- 2 months ago - BioPorto is proud to have Nine of the top-ten best US Children's hospitals as customers of NGAL - GlobeNewsWire
- 2 months ago - BioPorto A/S Announces Changes to the US Commercial Organization - GlobeNewsWire